litlas
Log inCreate account

Thomas N. Chase

Active 1968–2019

111
Papers
26,173
Citations
92
h-index
111
i10-index

Citations

Citations per year for Thomas N. Chase1969: 5 citations1970: 11 citations1971: 12 citations1972: 14 citations1973: 7 citations1974: 17 citations1975: 13 citations1976: 20 citations1977: 30 citations1978: 24 citations1979: 30 citations1980: 10 citations1981: 14 citations1982: 16 citations1983: 19 citations1984: 33 citations1985: 48 citations1986: 88 citations1987: 78 citations1988: 95 citations1989: 105 citations1990: 84 citations1991: 74 citations1992: 138 citations1993: 89 citations1994: 115 citations1995: 97 citations1996: 134 citations1997: 119 citations1998: 148 citations1999: 153 citations2000: 271 citations2001: 194 citations2002: 235 citations2003: 252 citations2004: 273 citations2005: 213 citations2006: 257 citations2007: 218 citations2008: 239 citations2009: 210 citations2010: 189 citations2011: 231 citations2012: 135 citations2013: 164 citations2014: 171 citations2015: 121 citations2016: 109 citations2017: 105 citations2018: 104 citations2019: 304 citations2020: 303 citations2021: 251 citations2022: 185 citations2023: 141 citations2024: 210 citations2025: 66 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,726 citing papers, 35.7% of this breakdownUnited Kingdom: 608 citing papers, 7.9% of this breakdownCanada: 448 citing papers, 5.9% of this breakdownFrance: 378 citing papers, 4.9% of this breakdownItaly: 374 citing papers, 4.9% of this breakdownGermany: 349 citing papers, 4.6% of this breakdownChina: 335 citing papers, 4.4% of this breakdownSweden: 261 citing papers, 3.4% of this breakdownSpain: 214 citing papers, 2.8% of this breakdownJapan: 214 citing papers, 2.8% of this breakdownAustralia: 188 citing papers, 2.5% of this breakdownNetherlands: 126 citing papers, 1.6% of this breakdown
0%35.7%Other 18.6%

Institutions

Fields

  • Medicine43.9%
  • Neuroscience33.4%
  • Biochemistry, Genetics and Molecular Biology10.7%
  • Environmental Science5.2%
  • Psychology3%
  • Earth and Planetary Sciences0.7%
  • Other3.1%

Topics

  • Parkinson's Disease Mechanisms and Treatments8.6%
  • Neurological disorders and treatments7.3%
  • Neuroscience and Neuropharmacology Research7.2%
  • Neurotransmitter Receptor Influence on Behavior5.9%
  • Receptor Mechanisms and Signaling4.1%
  • Dementia and Cognitive Impairment Research2.7%
  • Other64.2%

Coauthors

All papers

Open in search
  1. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity

    Authors: Christopher Randolph, Michael C. Tierney, Erich Mohr, Thomas N. Chase - Journal of Clinical and Experimental Neuropsychology 1998 cited by 2,529

  2. D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons

    Authors: Charles R. Gerfen, Thomas M. Engber, Lawrence C. Mahan, Zvi Susel, Thomas N. Chase, Frederick J. Monsma, David R. Sibley - Science 1990 cited by 2,970

  3. Degradation of α-Synuclein by Proteasome

    Authors: M. Catherine Bennett, John F. Bishop, Yan Leng, P Boon Chock, Thomas N. Chase, M. Maral Mouradian - Journal of Biological Chemistry 1999 cited by 412

  4. Apathy in Neuropsychiatric Disease: Diagnosis, Pathophysiology, and Treatment

    Authors: Thomas N. Chase - Neurotoxicity Research 2010 cited by 141

  5. Huntington’s disease

    Authors: Leo Verhagen Metman, Michael J. Morris, Cristan Farmer, Marjorie Gillespie, Karla J Mosby, Joanne Wuu, Thomas N. Chase - Neurology 2002 cited by 162

  6. Translating intracarotid artery transplantation of bone marrow-derived NCS-01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy

    Authors: Yuji Kaneko, Jea-Young Lee, Naoki Tajiri, Julian P. Tuazon, Trenton Lippert, Eleonora Russo, Seong‐Jin Yu, Brooke Bonsack, Sydney Corey, Alexandreya B. Coats, Chase Kingsbury, Thomas N. Chase, Minako Koga, Cesar V. Borlongan - Stem Cells Translational Medicine 2019 cited by 22

  7. Dopaminergic modulation of cortical function in patients with Parkinson's disease

    Authors: Venkata S. Mattay, Alessandro Tessitore, Joseph H. Callicott, Alessandro Bertolino, Terry E. Goldberg, Thomas N. Chase, Thomas M. Hyde, Daniel R. Weinberger - Annals of Neurology 2002 cited by 402

  8. Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

    Authors: Alessandro Tessitore, Ahmad R. Hariri, Francesco Saverio Fera, William G. Smith, Thomas N. Chase, Thomas M. Hyde, Daniel R. Weinberger, Venkata S. Mattay - Journal of Neuroscience 2002 cited by 290

  9. Stem Cells as an Emerging Paradigm in Stroke 3

    Authors: Sean I. Savitz, Steven C. Cramer, Lawrence R. Wechsler, Jaroslaw Aronowski, Johannes Boltze, Cesar V. Borlongan, Casey Case, Thomas N. Chase, Michael Chopp, S. Thomas Carmichael, Steven C. Cramer, Pamela W. Duncan, Seth P. Finklestein, Steven Fischkoff, Raphaël Guzman, David C. Hess, David Huang, Jim Hinson, Steven A. Kautz, Douglas Kondziolka, Robert W. Mays, Vivek Misra, Panos Mitsias, Michel Modo, Keith W. Muir, Sean I. Savitz, John D. Sinden, Evan Snyder, Gary K. Steinberg, Farhaan Vahidy, Lawrence R. Wechsler, Alison E. Willing, Steven L. Wolf, Ernest W. Yankee, Dileep R. Yavagal - Stroke 2013 cited by 152

  10. The influence of land-use change and landscape dynamics on the climate system: relevance to climate-change policy beyond the radiative effect of greenhouse gases

    Authors: Roger A. Pielke, Gregg Marland, Richard Betts, Thomas N. Chase, J. L. Eastman, John O. Niles, Dev Niyogi, Steven W. Running - Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences 2002 cited by 828

  11. Alzheimer's disease

    Authors: Norman L. Foster, Thomas N. Chase, Paul Fedio, Nicholas J. Patronas, Rodney A. Brooks, Giovanni Di Chiro - Neurology 1983 cited by 543

  12. Adenosine A 2A receptor antagonist treatment of Parkinson’s disease

    Authors: William Bara‐Jimenez, Ayesha Sherzai, Tzvetelina Dimitrova, Antonella Favit, Francesco Bibbiani, Marjorie Gillespie, Michael J. Morris, M. Maral Mouradian, Thomas N. Chase - Neurology 2003 cited by 327

  13. Cortical abnormalities in Alzheimer's disease

    Authors: Norman L. Foster, Thomas N. Chase, Luigi Mansi, Rodney A. Brooks, Paul Fedio, Nicholas J. Patronas, Giovanni Di Chiro - Annals of Neurology 1984 cited by 376

  14. Impacts of Land Use/Land Cover Change on Climate and Future Research Priorities

    Authors: Rezaul Mahmood, Roger A. Pielke, Kenneth G. Hubbard, Dev Niyogi, Gordon B. Bonan, Peter Lawrence, Richard T. McNider, Clive McAlpine, Andrés Etter, S. Gameda, Budong Qian, Andrew M. Carleton, Adriana Beltrán‐Przekurat, Thomas N. Chase, Arturo I. Quintanar, Jimmy Adegoke, Sajith Vezhapparambu, Glen Conner, S. Asefi, Elif Sertel, David R. Legates, Yuling Wu, Robert C. Hale, Oliver W. Frauenfeld, Anthony Watts, J. Marshall Shepherd, Chandana Mitra, Valentine Anantharaj, Souleymane Fall, Robert Lund, Anna M. Treviño, Peter D. Blanken, Jinyang Du, Hsin-I Chang, Ronnie Leeper, U. S. Nair, Scott Dobler, Ravinesh C. Deo, Jozef Syktus - Bulletin of the American Meteorological Society 2009 cited by 298

  15. Effects of serotonin 5‐HT1A agonist in advanced Parkinson's disease

    Authors: William Bara‐Jimenez, Francesco Bibbiani, Michael J. Morris, Tzvetelina Dimitrova, Abdullah Sherzai, M. Maral Mouradian, Thomas N. Chase - Movement Disorders 2005 cited by 155

  16. A trial of dextromethorphan in parkinsonian patients with motor response complications

    Authors: Leo Verhagen Metman, Pierre J. Blanchet, Pepÿn van den Munckhof, Paolo Del Dotto, Remco Natté, Thomas N. Chase - Movement Disorders 1998 cited by 81

  17. Representing a new MODIS consistent land surface in the Community Land Model (CLM 3.0)

    Authors: Peter Lawrence, Thomas N. Chase - Journal of Geophysical Research Atmospheres 2007 cited by 742

  18. Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II

    Authors: M. Maral Mouradian, J. L. Junecos, Giovanni Fabbrini, J.U. Schlegel, John J. Bartko, Thomas N. Chase - Annals of Neurology 1988 cited by 362

  19. Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys

    Authors: Stella M. Papa, Thomas N. Chase - Annals of Neurology 1996 cited by 290

  20. On‐off response

    Authors: Ira Shoulson, George Glaubiger, Thomas N. Chase - Neurology 1975 cited by 278

  21. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

    Authors: Thomas N. Chase, Justin D. Oh - Trends in Neurosciences 2000 cited by 251

  22. Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

    Authors: Stella M. Papa, Thomas M. Engber, Anne M. Kask, Thomas N. Chase - Brain Research 1994 cited by 236

  23. Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part I

    Authors: G. Fabbnni, M. Maral Mouradian, J. L. Junecos, J.U. Schlegel, Erich Mohr, Thomas N. Chase - Annals of Neurology 1988 cited by 214

  24. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s disease

    Authors: Francesco Bibbiani, Justin D. Oh, Jacobus P. Petzer, Neal Castagnoli, J.-F Chen, Michael A. Schwarzschild, Thomas N. Chase - Experimental Neurology 2003 cited by 204